Clinical Study

The Effect of Esmolol on Tissue Perfusion and Clinical Prognosis of Patients with Severe Sepsis: A Prospective Cohort Study

Table 3

The effect of esmolol on hemodynamics in patients with severe sepsis.

(Time, H)Esmolol group ()
Mean ± standard deviation
Control group ()
Mean ± standard deviation

Fluid intake
24 h4373.36 ± 571.864841.75 ± 658.89−4.663<0.01
48 h4189.61 ± 515.524720.74 ± 648.60−5.566<0.01
72 h3991.08 ± 486.734553.20 ± 591.72−6.371<0.01
HR
Base value125.04 ± 13.28127.21 ± 13.88−0.9820.328
24 h101.96 ± 7.36110.12 ± 8.59−6.272<0.01
48 h93.04 ± 4.52102.57 ± 6.91−10.039<0.01
72 h84.17 ± 6.2694.47 ± 7.91−8.861<0.01
MAP
Base value74.71 ± 7.2875.89 ± 6.61−1.0510.295
24 h68.65 ± 9.7268.54 ± 7.690.0800.936
48 h71.00 ± 11.8068.39 ± 7.531.6150.109
72 h70.91 ± 10.5768.14 ± 7.731.8290.069
CVP
Base value12.45 ± 3.1611.99 ± 3.350.8810.380
24 h10.04 ± 1.7210.04 ± 1.710.0020.998
48 h10.08 ± 1.439.83 ± 1.231.1580.249
72 h9.77 ± 1.609.91 ± 1.64−0.5100.611
IS
Base value10.99 ± 2.0811.11 ± 1.81−0.3740.709
24 h10.92 ± 1.3910.74 ± 1.400.7940.428
48 h9.56 ± 1.189.51 ± 1.440.2430.808
72 h9.09 ± 1.249.29 ± 1.23−0.9570.340